Jacobsen F, Lundbeck F, Vaeth M, Kjaer T B
Department of Urology, Aarhus Municipal Hospital, Denmark.
Scand J Urol Nephrol Suppl. 1987;104:123-5.
Forty-six newly diagnosed patients with T1 and T2 bladder tumours were treated with radical transurethral resection. During a six-month period more than 50% of the tumours recurred. Subsequently progression of tumours was seen within 24 months in 30 and 50% of the patients with T1 and T2 tumours, respectively. Prognosis with regard to the progression was significantly better in patients with Ta recurrence at first TUR control than in patients with invasive recurrent tumours.
46例新诊断的T1和T2期膀胱肿瘤患者接受了根治性经尿道切除术。在6个月期间，超过50%的肿瘤复发。随后，T1期和T2期肿瘤患者分别在24个月内出现肿瘤进展，比例分别为30%和50%。首次经尿道切除术后Ta期复发的患者在肿瘤进展方面的预后明显好于浸润性复发肿瘤的患者。
